EUS-Guided Drainage of Refractory Malignant Ascites

Andalusian Health Service

Status: Unknown

Conditions: Malignant Ascites

Treatments: Procedure: EUS-Guided drainage

Study type: Observational

Funder types: Other

Identifiers

NCT03550560

JBO-ECO-2017-01

Details and patient eligibility

About

This study evaluates the efficacy and safety of drainage of refractory malignant ascites by endoscopic ultrasound-guided (EUS-Guided) implantation of plastic prostheses. Patients with cancer older than 18 years with a life expectancy of less than 6 months who undergo EUS-Guided will be included in the study.

Full description

Malignant ascites is described as the presence of fluid in the abdominal cavity due to the presence of tumors. Its appearance is a predictor of worse prognosis in the evolution of malignant neoplasm and reduces the quality of life of patients.

The use of prostheses with drainage to the gastric cavity has shown good clinical results as the reduction of paracentesis evacuation needs. This achieves the reduction of hospital admissions and the improvement of the quality of life of the patient.

In order to verify the usefulness of this drainage technique, a prospective observational study has been designed. Patients with cancer over 18 years of age will be included, with a life expectancy of less than 6 months and who have undergone drainage of refractory malignant ascites through the implantation of plastic prostheses.

Participants receive the intervention in the same manner and intensity if they are not enrolled in the study.

Enrollment: 100 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Cancer patients in terminal phase with refractory malignant ascites older 18 years of age

Exclusion criteria

• Patients under 18 years of age
• Patients with a life expectancy greater than 6 months
• Patients who are receiving cancer treatment for curative purposes or who suffer from a psychiatric disorder that prevents them from understanding and accepting the procedure
• Patients who do not accept to participate in the study.

Trial design

100 participants in 1 patient group

EUS-Guided drainage

Description:

Cancer patients in terminal phase with refractory malignant ascites

Treatment:

Procedure: EUS-Guided drainage